Key result
Bioprosthetic valve fracture during ViV TAVR improves hemodynamics and expansion despite slightly increased operative risk.
Why the study?
Transcatheter aortic valve-in-valve replacement carries a major drawback of poor hemodynamics due to reduced valvular diameter, which bioprosthetic valve fracture aims to address.
Does bioprosthetic valve fracture improve hemodynamic outcomes in patients undergoing transcatheter aortic valve-in-valve replacement?
Systematic Review
Does bioprosthetic valve fracture improve hemodynamic outcomes in patients undergoing transcatheter aortic valve-in-valve replacement?
Bioprosthetic valve fracture during transcatheter aortic valve-in-valve replacement improves hemodynamics and valve expansion, albeit with slightly increased operative risk.
Valve fracture may mitigate mismatch in valve-in-valve TAVR; leaves open need for prospective outcome data.
Transcatheter aortic valve-in-valve replacement presents a viable, minimally invasive approach to replacing degraded bioprosthetic surgical valves. The major drawback of this technique is poor hemodynamics in the form of patient-prosthesis mismatch and high transvalvular gradients. This is commonly attributable to the reduced valvular diameter from the transcatheter heart valve fixed inside the degraded bioprosthesis. Maximizing this diameter by bioprosthetic valve fracture occurs through a noncompliant, high-pressure balloon to splay the degraded valve outward. Despite its novelty, this has demonstrated improved hemodynamic outcomes and optimal valvular expansion with slightly increased operative risk. In this review, we highlight the technique of bioprosthetic valve fracture, types of suitable balloons and valves, timing in relation to valve-in-valve implantation, safety and efficacy, implications, and future directions.
No takes yet. Share an insight, caveat, or question.
Chopko et al. (2025) conducted a systematic review in Degraded bioprosthetic surgical valves requiring transcatheter aortic valve-in-valve replacement. Bioprosthetic valve fracture was evaluated. Bioprosthetic valve fracture during transcatheter aortic valve-in-valve replacement demonstrates improved hemodynamic outcomes and optimal valvular expansion with slightly increased operative risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: